This Educational course organised by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function was held at the European Heart House on 12-13 October 2007.
Directed primarily at cardiologists and pulmologists, this course adresses the importance of screening and proper diagnostic algorithms, explores the relationship between treatment and survival outcomes, provides guidance on better treatment adherence and reviews the newest tools for evaluation treatment.
This educational training programme and online resources are supported by unrestricted educational grants from Actelion Pharmaceuticals Ltd and Encysive Pharmaceuticals Ltd.
Formats available for download below:
Play webcast
| SESSION 1: PATHOBIOLOGY, PATHOPHYSIOLOGY, EPIDEMIOLOGY |
|
|
Introduction
N. Galiè
|
|
 |
Case of Familial PAH
B. Sztrymf
|
|
|
Pathobiology of PAH
S. Adnot
|
|
 |
Case of PAH with haemodynamic, echocardiographic and NMR data
S. Gibbs
|
|
 |
Pathophysiology of Right Ventricle and Pulmonary Circulation in PH
R. Naeije
|
|
 |
Epidemiology of PAH
S. Gaine
|
|
|
SESSION 2: DIAGNOSIS AND PROGNOSIS
|
 |
Complex Clinical Case with Diagnostic Pitfalls
J.A. Barberà
|
|
|
Diagnostic Algorithm of PAH
N. Galiè
|
|
 |
PAH case/s with echocardigraphic insights
M. Kurzyna
|
|
 |
Role of Echocardiography in PAH
A. Torbicki
|
|
 |
PAH case/s with pitfalls in exercise capacity assessments
C. Opitz
|
|
 |
Exercise capacity assessment in PAH
S. Provencher
|
|
 |
PAH cases with haemodynamic insights
M. Delcroix
|
|
 |
Importance of haemodynamic evaluation in PAH
O. Sitbon
|
|
|
Biological Markers and Prognostic assessment in PAH
A. Torbicki
|
|
| SESSION 3: TREATMENT |
 |
PAH cases related to treatment
I. Lang
|
|
 |
Treatment Algorithm for PAH
G. Simmoneau
|
|
|
Shall we use the same strategy in any PAH patient?
N. Galiè
|
|
 |
PAH case/s with combination therapy
H. Olschewski
|
|
 |
Combination Therapy for PAH
M. Hoeper
|
|
 |
Surgical treatment of PAH and CTEPH: when and how
P. Dartevelle
|
|